药物及疫苗预防

更新于 2026年11月17日 版权声明
三、药物及疫苗预防

在一项研究中,一位发生针扎伤的医护人员预防性用了病毒唑,随后没有发生CCHF。1974年为CCHF流行地区的医护人员和军人推行免疫接种计划,疫苗为乳鼠脑制剂氯仿灭活,计划用疫苗帮助减少该地区的病例数和病死率。保加利亚的583名志愿者也接种了疫苗,其中96.6%产生了抗体。乳鼠脑福尔马林灭活疫苗已在保加利亚、东欧其他地区以及前苏联使用。然而,预防CCHFV的疫苗接种是有限的,而且仅限于少数几个地方。由于疫苗的制备方法,许多国家不适合使用这种疫苗,因此需要新的CCHFV疫苗平台。一个由CCHFV研究人员组成的国际合作组织已经开始研制CCHFV疫苗并将其带到临床,一些疫苗已经在临床前试验中显示出希望。一种表达CCHFV糖蛋白的重组痘苗病毒显示对致死剂量攻击的小鼠有100%的保护作用。基于DNA的疫苗或病毒样颗粒疫苗也能提供抵御致死性CCHFV的攻击。

向前往有地方性流行地区的人们告知防止蜱叮咬的控制措施(如驱虫剂、穿长袖衣服和长裤),发现蜱时需要戴手套去除蜱以及接触牲畜和操作肉类时的污染风险,对于预防发病也是需要的。

(唐 青)

参考文献

[1]Adams MJ,Lefkowitz EJ,King AMQ,et al.Changes to taxonomy and the International code of virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses (2017) [J].Arch Virol,2017,162 (8) :2505-2538.

[2]Casals J.Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus[J].Proc Soc Exp Biol Med,1969,131 (1) :233-236.

[3]Alkhovsky SV,Lvov DK,Shchetinin AM,et al.Complete genome coding sequences of Artashat,Burana,Caspiy,Chim,Geran,Tamdy,and Uzun-Agach Viruses (bunyavirales:nairoviridae:orthonairovirus)[J] .Genome Announc,2017,5 (40) :e01098-17.

[4]Korolev MB,Donets MA,Rubin SG,et al.Morphology and morphogenesis of Crimean hemorrhagic fever virus[J].Arch Virol,1976,50 (1/2) :169-172.

[5]Zivcec M,Metcalfe MG,Albarino CG,et al.Assessment of inhibitors of pathogenic Crimean-Congo hemorrhagic fever virus strains using virus-like particles[J].PLoS Negl Trop Dis,2015,9:e0004259.

[6]Barnwal B,Karlberg H,Mirazimi A,et al.Non-structural protein of Crimean-Congo hemorrhagic fever virus disrupts mitochondrial membrane potential and induces apoptosis[J].J Biol Chem,2015,291:582-592.

[7]Bertolotti-Ciarlet A,Smith J,Strecker K,et al.Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins[J].J Virol,2005,79 (10) :6152-6161.

[8]Bergeron E,Albario CG,Khristova ML,et al.Crimean-Congo hemorrhagic fever virusencoded ovarian tumor protease activity is dispensable for virus RNA polymerase function[J].J Virol,2010,84,216–226.

[9]Shi X,van Mierlo JT,French A,et al.Visualizing the replication cycle of bunyamwera orthobunyavirus expressing fluorescent protein-tagged Gc glycoprotein[J].J Virol,2010,84 (17) :8460-8469.

[10]Filltre P,Revest M,Tattevin P,et al.Crimean-Congo hemorrhagic fever:An update[J].Med Mal Infect,2020,50 (1) :95-96.

[11]Whitehouse CA.Crimean-Congo hemorrhagic fever[J].Antiviral Res,2004,64 (3) :145-160.

[12]Papa A,Christova I,Papadimitriou E,et al.Crimean-Congo hemorrhagic fever in Bulgaria[J].Emerg Infect Dis,2004,10:1465-1467.

[13]Ergnül O.Crimean-Congo haemorrhagic fever[J].Lancet Infect Dis,2006,6 (4) :203-214.

[14]Deyde VM,Khristova ML,Rollin PE,et al.Crimean-Congo hemorrhagic fever virus genomics and global diversity[J].J Virol,2006,80 (17) :8834-8842.

[15]Bente DA,Forrester NL,Watts DM,et al.Crimean-Congo hemorrhagic fever:history,epidemiology,pathogenesis,clinical syndrome and genetic diversity[J].Antiviral Res,2013,100(1) :159-89.

[16]Deyde VM,Khristova ML,Rollin PE,et al.Crimean-Congo hemorrhagic fever virus genomics and global diversity[J].J Virol,2006,80 (17) :8834-8842.

[17]Chumakov MP.On 30 years of investigation of Crimean hemorrhagic fever[J].Trudi Inst Polio Virusn Entsefalitov Akad Med.Nauk SSSR 22,1974:5-18

[18]Casals J,Henderson BE,Hoogstraal H,et al.A review of Soviet viral hemorrhagic fevers,1969[J].J Infect Dis,1970,122 (5) :437-453.

[19]Gargili A,Estrada-Pena A,Spengler JR,et al.The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus:A review of published field and laboratory studies[J].Antiviral Res,2017,144:93-119.

[20]Mallhi TH,Khan YH,Sarriff A,et al.Crimean-Congo haemorrhagic fever virus and Eid-Ul-Adha festival in Pakistan[J].Lancet Infect Dis,2016,16 (12) :1332-1333.

[21]Shepherd AJ,Swanepoel R,Leman PA,et al.Field and laboratory investigation of Crimean-Congo haemorrhagic fever virus (Nairovirus,family Bunyaviridae) infection in birds[J].Trans R Soc Trop Med Hyg,1987,81 (6) :1004-1007.

[22]Nuttall PA,Jones LD,Labuda M,et al.Adaptations of arboviruses to ticks[J].J Med Entomol,1994,31 (1) :1-9.

[23]Randolph SE.Transmission of tick-borne pathogens between co-feeding ticks:Milan Labuda′s enduring paradigm[J].Ticks Tick Borne Dis,2011,2 (4) :179-182.

[24]Spengler JR,Bergeron 图示,Rollin PE.Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals[J].PLoS Negl Trop Dis,2016,10 (1) :e0004210.

[25]Estrada-Pena A,Ayllón N,de la Fuente J.Impact of climate trends on tick-borne pathogen transmission[J].Front Physiol,2012,3:64.

[26]Leblebicioglu H,Ozaras R,Fletcher TE,et al.Crimean-Congo haemorrhagic fever in travellers:A systematic review[J].Travel Med Infect Dis,2016,14 (2) :73-80.

[27]Al-Abri SS,Abaidani IA,Fazlalipour M,et al.Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region:issues,challenges,and future directions[J].Int J Infect Dis,2017,58:82-89.

[28]Leblebicioglu H.Crimean-Congo haemorrhagic fever in Eurasia[J].Int J Antimicrob Agents,2010,36 Suppl 1:S43-S46.(https://www.daowen.com)

[29]Ahmeti S,Berisha L,Halili B,et al.Crimean-Congo Hemorrhagic Fever,Kosovo,2013-2016.Emerg Infect Dis,2019,25 (2) :321-324.

[30]Papa A,Dalla V,Papadimitriou E,et al.Emergence of Crimean-Congo haemorrhagic fever in Greece[J].Clin Microbiol Infect,2010,16 (7) :843-847.

[31]Mahzounieh M,Dincer E,Faraji A,et al.Relationship between Crimean-Congo hemorrhagic fever virus strains circulating in Iran and Turkey:possibilities for transborder transmission[J].Vector Borne Zoonotic Dis,2012,12 (9) :782-785.

[32]Zohaib A,Saqib M,Athar MA,et al.Crimean-Congo Hemorrhagic Fever Virus in Humans and Livestock,Pakistan,2015-2017[J].Emerg Infect Dis,2020,26 (4) :773-777.

[33]冯崇慧.新疆出血热病毒抗原性的初步分析[J].中华流行病学杂志,1983,4:92-95。

[34]Camp JV,Kannan DO,Osman BM,et al.Crimean-Congo Hemorrhagic Fever Virus Endemicity in United Arab Emirates,2019[J].Emerg Infect Dis,2020,26 (5) :1019-1021.

[35]Leblebicioglu H,Ozaras R,Irmak H,et al.Crimean-Congo hemorrhagic fever in Turkey:Current status and future challenges[J].Antiviral Res,2016,126:21-34.

[36]Grard G,Drexler JF,Fair J,et al.Re-emergence of Crimean-Congo hemorrhagic fever virus in Central Africa[J].PLoS Negl Trop Dis,2011,5 (10) :e1350.

[37]Swanepoel R,Shepherd AJ,Leman PA,et al.Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa[J].Am J Trop Med Hyg,1987,36 (1) :120-132.

[38]Yilmaz GR,Buzgan T,Irmak H,et al.The epidemiology of Crimean-Congo hemorrhagic fever in Turkey,2002-2007[J].Int J Infect Dis,2009,13 (3) :380-386.

[39]Leblebicioglu H,Sunbul M,Guner R,et al.Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey,2002-2014:a multicentre retrospective cross-sectional study[J].Clin Microbiol Infect,2016,22 (4) :387.e1-387.e4.

[40]Swanepoel R,Gill DE,Shepherd AJ,et al.The clinical pathology of Crimean-Congo hemorrhagic fever[J].Rev Infect Dis,1989,11 Suppl 4:S794-S800.

[41]Ozturk B,Kuscu F,Tutuncu E,et al.Evaluation of the association of serum levels of hyaluronic acid,sICAM-1,sVCAM-1,and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever[J].J Clin Virol,2010,47 (2) :115-119.

[42]Ergonul O,Tuncbilek S,Baykam N,et al.Evaluation of serum levels of interleukin (IL)-6,IL-10,and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever[J].J Infect Dis,2006,193 (7) :941-944.

[43]Yilmaz M,Aydin K,Akdogan E,et al.Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever[J].J Clin Virol,2008,42 (4) :415-417.

[44]Shepherd AJ,Swanepoel R,Leman PA.Antibody response in Crimean-Congo hemorrhagic fever[J].Rev Infect Dis,1989,11 Suppl 4:S801-S806.

[45]Burt FJ,Swanepoel R,Shieh WJ,et al.Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis[J].Arch Pathol Lab Med,1997,121 (8) :839-846.

[46]Shepherd AJ,Swanepoel R,Leman PA,et al.Comparison of methods for isolation and titration of Crimean-Congo hemorrhagic fever virus[J].J Clin Microbiol,1986,24 (4) :654-656.

[47]Donets MA,Rezapkin GV,Ivanov AP,et al.Immunosorbent assays for diagnosis of Crimean-Congo hemorrhagic fever (CCHF)[J].Am J Trop Med Hyg,1982,31 (1) :156-162.

[48]Burt FJ,Leman PA,Abbott JC,Swanepoel R.Serodiagnosis of Crimean-Congo haemorrhagic fever[J].Epidemiol Infect,1994,113 (3) :551-562.

[49]Saijo M,Qing T,Niikura M,et al.Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus[J].J Clin Microbiol,2002,40 (2) :372-375.

[50]Emmerich P,Mika A,von Possel R,et al.Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests[J].PLoS Negl Trop Dis,2018,12 (3) :e0006366.

[51]Koehler JW,Delp KL,Hall AT,et al.Sequence optimized real-time reverse transcription Polymerase chain reaction assay for detection of crimean-congo hemorrhagic fever virus[J].Am J Trop Med Hyg,2018,98 (1) :211-215.

[52]Schwarz TF,Nsanze H,Ameen AM.Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates[J].Infection,1997,25 (6) :364-367.

[53]Tasdelen Fisgin N,Ergonul O,Doganci L,et al.The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever:early use is promising[J].Eur J Clin Microbiol Infect Dis,2009,28 (8) :929-933.

[54]Mardani M,Jahromi MK,Naieni KH,et al.The efficacy of oral ribavirinin the treatment of crimean-congo hemorrhagic fever in Iran[J].Clin Infect Dis,2003,36 (12) :1613–1618.

[55]Ertem G,Snmezer M,Temoin F,et al.The efficacy of oral ribavirin on clinical and laboratory parameters inCrimean-Congo hemorrhagic fever:an observational study from Turkey[J].Turk J Med Sci,2016,46 (5) :1407-1414.

[56]Ergnül ,Keske S,Celdir MG,et al.Systematic review and meta-analysis of postexposure prophylaxis forCrimean-Congo hemorrhagic fever virus among healthcare workers[J].Emerg Infect Dis,2018,24 (9) :1642–1648

[57]Soares-Weiser K,Thomas S,Thomson G,et al.Ribavirin for Crimean-Congo hemorrhagic fever:systematic review and meta-analysis[J].BMC Infect Dis,2010,10:207.70.

[58]Sharifi-Mood B,Alavi-Naini R,Metanat M,et al.Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia[J].Trop Doct,2013,43 (2) :49-53.

[59]Vassilev T,Valchev V,Kazarov G,et al.A reference preparation for human immunoglobulin against Crimean/Congo hemorrhagic fever[J].Biologicals,1991,19 (1) :57.

[60]Tkachenko EA,Butenko AM,Badalov MY,et al.Investigation of immunogenic activity of killed brain vaccine against Crimean hemorrhagic fevers[J].Academy of Medical Sciences,Moscow,USSR,1971:119–129.

✍AI写作